CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
For the period ended Mar 31, 2025. Filed May 9, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 9, 2025
CELZ$0.62+2.6%Stored close · as of Nov 6, 2026
Contents
Unaudited Condensed Consolidated Balance Sheets
| March 31, 2025 | December 31, 2024 | |
|---|---|---|
| ASSETS | ||
| CURRENT ASSETS | ||
| Cash | $7,702,867 | $5,940,402 |
| Inventory | 994 | 2,194 |
| Prepaids and other current assets | 140,150 | 192,707 |
| Total Current Assets | 7,844,011 | 6,135,303 |
| OTHER ASSETS | ||
| Other assets | 3,281 | 3,281 |
| Licenses, net of amortization | 499,982 | 530,559 |
| TOTAL ASSETS | $8,347,274 | $6,669,143 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| CURRENT LIABILITIES | ||
| Accounts payable | $272,193 | $273,530 |
| Accrued expenses | - | 39,920 |
| Advances from related party | 14,194 | 14,194 |
| Total Current Liabilities | 286,387 | 327,644 |
| TOTAL LIABILITIES | 286,387 | 327,644 |
| Commitments and contingencies | ||
| STOCKHOLDERS’ EQUITY | ||
| Common stock, $0.001 par value, 25,000,000 shares authorized; 2,585,532 and 1,748,428 issued and 2,580,532 and 1,748,428 outstanding at March 31, 2025 and December 31, 2024, respectively | 2,586 | 1,749 |
| Additional paid-in capital | 74,298,311 | 70,931,663 |
| Accumulated deficit | (66,230,010) | (64,591,913) |
| Treasury stock, at cost, 5,000 and 0 shares as of March 31, 2025 and December 31, 2024, respectively | (10,000) | - |
| TOTAL STOCKHOLDERS’ EQUITY | 8,060,887 | 6,341,499 |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $8,347,274 | $6,669,143 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.